Financials in USD. Standardized financial statements.
A compact view of how Genetron Holdings Limited turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue? | $650.71M | $531.95M | $424.49M | $323.43M | $225.18M | $101.03M |
| Revenue Growth? | +22.3% | +25.3% | +31.2% | +43.6% | +122.9% | 0.0% |
| Cost of Revenue? | $369.28M | $193.98M | $164.27M | $178.44M | $132.45M | $74.21M |
| Gross Profit? | $281.43M | $337.97M | $260.22M | $144.99M | $92.73M | $26.82M |
| Gross Margin? | +43.2% | +63.5% | +61.3% | +44.8% | +41.2% | +26.5% |
| Operating Expenses? | $913.05M | $818.78M | $513.75M | $451.58M | $332.19M | $181.01M |
| Operating Income? | -$631.62M | -$480.82M | -$253.53M | -$306.59M | -$232.98M | -$152.54M |
| EBITDA? | -$651.24M | -$460.31M | -$201.69M | -$625.81M | -$212.21M | -$134.08M |
| Income Before Tax | -$810.63M | -$502.60M | -$3.07B | -$676.03M | -$464.99M | -$420.64M |
| Income Tax Expense | $73.26M | -$64.19M | -$2.87B | -$354.54M | -$232.02M | $0 |
| Net Income? | -$883.89M | -$438.40M | -$198.10M | -$321.49M | -$464.99M | -$420.64M |
| EPS? | $-28.53 | $-4.76 | $-3.29 | $-4.65 | $-6.73 | $-6.22 |
| Diluted EPS? | $-28.53 | $-4.76 | $-3.29 | $-4.65 | $-6.73 | $-6.22 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality